Patents by Inventor Eustrate Avrameas

Eustrate Avrameas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8003595
    Abstract: The invention concerns an amino acid sequence capable of facilitating penetration of a substance of interest into cells and/or cell nuclei, characterized in that it is capable of reacting in vivo with aminoglycans. Optionally the sequence is derived from a protein of human origin.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: August 23, 2011
    Assignee: Cellectis
    Inventors: Eustrate Avrameas, Therese Ternynck
  • Publication number: 20030199677
    Abstract: The invention concerns an amino acid sequence capable of facilitating penetration of a substance of interest into cells and/or cell nuclei, characterized in that it is capable of reacting in vivo with aminoglycans. Optionally the sequence is derived from a protein of human origin.
    Type: Application
    Filed: August 29, 2002
    Publication date: October 23, 2003
    Inventors: Eustrate Avrameas, Therese Ternynck
  • Patent number: 4677055
    Abstract: A process for the immunobacteriological detection of pathogenic germs possessing specific antigenic determinants, and a kit for carrying out the process, with the aid of a magnetic gel to which are coupled anti-specific antigenic determinant antibodies, characterized by the following steps:(a) a biological medium supposedly contaminated by a pathogenic germ possessing a specific antigenic determinant is brought into contact with particles of the magnetic gel,(b) the particles of magnetic gel are then removed by magnetic means and(c) are inoculated onto a nutrient agar medium,(d) the agar medium is incubated to develop culture colonies of the pathogenic germs;(e) areas containing serum containing antibodies specific to the pathogenic germ to be detected are formed in the agar,(f) the germs are lysed by means of lysing agents,(g) the lysate is incubated with the serum for a time enabling the serological antibody-antigen reaction to take place by immunodiffusion on the agar, and(h) the quantity of germs containe
    Type: Grant
    Filed: December 7, 1983
    Date of Patent: June 30, 1987
    Assignee: Institut Pasteur
    Inventors: Andre Dodin, Eustrate Avrameas, Bruno Goud, Michel Guillou, Renee Nicolas